Mednax Inc Net Income
| MD Stock | USD 19.85 0.01 0.05% |
As of the 1st of March, Mednax secures the Standard Deviation of 2.44, mean deviation of 1.71, and Risk Adjusted Performance of (0.06). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mednax Inc, as well as the relationship between them. Please verify Mednax Inc mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Mednax Inc is priced some-what accurately, providing market reflects its recent price of 19.85 per share. Given that Mednax Inc has information ratio of (0.12), we recommend you to check Mednax's last-minute market performance to make sure the company can sustain itself at a future point.
Mednax Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.9804 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 165.4 M | 173.7 M | |
| Net Income Applicable To Common Shares | 165.4 M | 173.7 M | |
| Net Loss | -89.2 M | -84.7 M | |
| Net Income Per Share | 1.94 | 2.04 | |
| Net Income Per E B T | 0.76 | 0.80 |
Mednax | Net Income | Build AI portfolio with Mednax Stock |
Analyzing Mednax's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Mednax's current valuation and future prospects.
Latest Mednax's Net Income Growth Pattern
Below is the plot of the Net Income of Mednax Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Mednax Inc financial statement analysis. It represents the amount of money remaining after all of Mednax Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Mednax's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 165.39 M | 10 Years Trend |
|
Net Income |
| Timeline |
Mednax Net Income Regression Statistics
| Arithmetic Mean | 23,236,141 | |
| Geometric Mean | 187,122,808 | |
| Coefficient Of Variation | 2,053 | |
| Mean Deviation | 301,699,730 | |
| Median | 173,657,400 | |
| Standard Deviation | 476,922,206 | |
| Sample Variance | 227454.8T | |
| Range | 1.8B | |
| R-Value | (0.22) | |
| Mean Square Error | 230958.5T | |
| R-Squared | 0.05 | |
| Significance | 0.40 | |
| Slope | (20,704,448) | |
| Total Sum of Squares | 3639276.6T |
Mednax Net Income History
Other Fundumenentals of Mednax Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Mednax Net Income component correlations
Mednax Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Mednax is extremely important. It helps to project a fair market value of Mednax Stock properly, considering its historical fundamentals such as Net Income. Since Mednax's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mednax's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mednax's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.114 | Earnings Share 1.91 | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value - what Mednax's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Mednax 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mednax's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mednax.
| 12/01/2025 |
| 03/01/2026 |
If you would invest 0.00 in Mednax on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Mednax Inc or generate 0.0% return on investment in Mednax over 90 days. Mednax is related to or competes with National HealthCare, Select Medical, Acadia Healthcare, Astrana Health, Aveanna Healthcare, Ardent Health, and Lifestance Health. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, a... More
Mednax Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mednax's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mednax Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 15.59 | |||
| Value At Risk | (3.75) | |||
| Potential Upside | 3.16 |
Mednax Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mednax's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mednax's standard deviation. In reality, there are many statistical measures that can use Mednax historical prices to predict the future Mednax's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.23) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mednax's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mednax March 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 1.71 | |||
| Coefficient Of Variation | (1,225) | |||
| Standard Deviation | 2.44 | |||
| Variance | 5.95 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 15.59 | |||
| Value At Risk | (3.75) | |||
| Potential Upside | 3.16 | |||
| Skewness | (1.76) | |||
| Kurtosis | 7.78 |
Mednax Inc Backtested Returns
Mednax Inc has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12 % return per unit of risk over the last 3 months. Mednax exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mednax's Risk Adjusted Performance of (0.06), mean deviation of 1.71, and Standard Deviation of 2.44 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.9, which conveys possible diversification benefits within a given portfolio. Mednax returns are very sensitive to returns on the market. As the market goes up or down, Mednax is expected to follow. At this point, Mednax Inc has a negative expected return of -0.28%. Please make sure to verify Mednax's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Mednax Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.20 |
Weak predictability
Mednax Inc has weak predictability. Overlapping area represents the amount of predictability between Mednax time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mednax Inc price movement. The serial correlation of 0.2 indicates that over 20.0% of current Mednax price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.8 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Mednax Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Mednax Inc reported net income of 165.39 M. This is 51.54% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 71.03% higher than that of the company.
Mednax Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednax's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mednax could also be used in its relative valuation, which is a method of valuing Mednax by comparing valuation metrics of similar companies.Mednax is currently under evaluation in net income category among its peers.
Mednax ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mednax's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mednax's managers, analysts, and investors.Environmental | Governance | Social |
Mednax Institutional Holders
Institutional Holdings refers to the ownership stake in Mednax that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Mednax's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mednax's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.3 M | Charles Schwab Investment Management Inc | 2025-06-30 | 1.3 M | Renaissance Technologies Corp | 2025-06-30 | 1.2 M | Northern Trust Corp | 2025-06-30 | 909.9 K | Nuveen, Llc | 2025-06-30 | 839.6 K | Goldman Sachs Group Inc | 2025-06-30 | 790.5 K | Cinctive Capital Management Lp | 2025-06-30 | 775.7 K | Pacer Advisors, Inc. | 2025-06-30 | 772.9 K | Dana Investment Advisors Inc | 2025-06-30 | 759.3 K | Blackrock Inc | 2025-06-30 | 13.9 M | Vanguard Group Inc | 2025-06-30 | 11 M |
Mednax Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0657 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.88 B | ||||
| Shares Outstanding | 85.88 M | ||||
| Shares Owned By Insiders | 2.48 % | ||||
| Shares Owned By Institutions | 97.52 % | ||||
| Number Of Shares Shorted | 2.96 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 1.91 X | ||||
| Price To Sales | 0.90 X | ||||
| Revenue | 1.91 B | ||||
| Gross Profit | 493.7 M | ||||
| EBITDA | 274.22 M | ||||
| Net Income | 165.39 M | ||||
| Cash And Equivalents | 375.24 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 660.3 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 10.68 X | ||||
| Cash Flow From Operations | 271.09 M | ||||
| Short Ratio | 5.53 X | ||||
| Earnings Per Share | 1.91 X | ||||
| Price To Earnings To Growth | 0.88 X | ||||
| Target Price | 21.33 | ||||
| Number Of Employees | 4.28 K | ||||
| Beta | 0.78 | ||||
| Market Capitalization | 1.73 B | ||||
| Total Asset | 2.25 B | ||||
| Retained Earnings | (83.15 M) | ||||
| Working Capital | 205.5 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
| Net Asset | 2.25 B |
About Mednax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednax Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednax Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.114 | Earnings Share 1.91 | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value - what Mednax's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.